s18986
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2005 (NCT00202540)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate receptor AMPA 1/2ACTIVATOR
Glutamate receptor AMPA 1/2 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s18986
- s18986
- s18986
- s 18986
- s-18986
- s 18986-1
- s18986-1
- (s)-2,3-dihydro-(3,4)cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00202540 | Phase 2 | Jun 1, 2005 | Servier |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Servier | For profit | 1 | 1 | 1 | 2005 |
1 organizations
Page 1 / 1